NCT01339273

Brief Summary

Laparoscopic (key-hole) large bowel resection is a minimally invasive procedure when compared to open large bowel resection, but is still associated with a significant amount of pain and discomfort. Analgesia is commonly provided by a multi-modal technique involving varying combinations of paracetamol, Non steroidal anti-inflammatory drugs (NSAIDs), regional analgesia and oral or parenteral opioids. While epidural analgesia is considered the gold standard for open colo-rectal procedures it can be associated with significant complications and may delay hospital discharge in laparoscopic procedures. Opioids are associated with an increased incidence of nausea, vomiting and sedation and reduced bowel motility which can also prolong recovery. Transversus Abdominis Plane (TAP) block is a technique which numbs the nerves carrying pain sensation from the abdominal wall and provides effective and safe analgesia with minimal systemic side effects. Their perceived benefits are thought to relate to reduced opioid consumption and therefore reduced opioid side effects. The investigators believe ultrasound guided TAP blocks will reduce pain and morphine consumption with a resultant improved patient satisfaction, earlier return of bowel function and earlier hospital discharge. The key research question the investigators are trying to answer is whether TAP block provide better pain relief than local anaesthetic infiltration of the laparoscopic port sites. Both techniques are currently being used in our hospital and a retrospective audit demonstrated better analgesia and lower consumption of morphine in the TAP block group.The differences were not statistically significant as the number patients in the audit were not large enough.The investigators are hoping that this study will demonstrate that the difference is real by recruiting the necessary number of patients into each group (36 per group)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 20, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

February 5, 2020

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

2.3 years

First QC Date

April 18, 2011

Results QC Date

November 21, 2019

Last Update Submit

January 24, 2020

Conditions

Keywords

TAP blockLaparoscopic hemicolectomyLaparoscopic anterior resectionlaparoscopic colonic resection

Outcome Measures

Primary Outcomes (1)

  • Morphine Consumption in the First 48hours After the Operation

    Total morphine consumption in the first 48 hours after the surgery will be calculated from the drug chart and the Patient controlled analgesia(PCA)pump.

    48 hours after the operation

Secondary Outcomes (13)

  • Numerical Rating Pain Scores at 48 Hours Postoperatively

    48 hours after the operation

  • Nausea Score at 48 Hours Postoperatively

    48 hours after the operation

  • Time to First Request for Rescue Analgesia

    After the operation patients will be followed up till they are medically fit to be discharged from the hospital an expected average of 5-7 days.

  • Time to Mobilisation

    After the operation patients will be followed up till they are medically fit to be discharged from the hospital an expected average of 5-7 days.

  • Time to Successful Intake of Fluids

    After the operation patients will be followed up till they are medically fit to be discharged from the hospital an expected average of 5-7 days.

  • +8 more secondary outcomes

Study Arms (2)

TAP block

EXPERIMENTAL

Patients in this arm will receive ultrasound guided TAP bock with Bupivacaine 0.25% 20ml per side or to a maximum 1mg/kg per side and the skin puncture will be covered with a small plaster

Procedure: Ultrasound guided Transversus Abdominis Plane (TAP) bock

Local anaesthetic infiltration

ACTIVE COMPARATOR

Laparoscopic port sites and specimen extraction site will be infiltrated with a total of 40 mls 0.25% bupivacaine subcutaneously at the end of the procedure in the control group and plasters will be stuck on either side approximately where a skin puncture for tap block would be made.

Procedure: Local anaesthetic infiltration of laparoscopic port sites

Interventions

Ultrasound guided TAP bock with Bupivacaine 0.25% 20ml per side or to a maximum 1mg/kg per side and the skin puncture will be covered with a small plaster

TAP block

Laparoscopic port sites and specimen extraction site will be infiltrated with a total of 40 mls 0.25% bupivacaine subcutaneously at the end of the procedure in the control group and plasters will be stuck on either side approximately where a skin puncture for tap block would be made.

Local anaesthetic infiltration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Undergoing elective laparoscopic high anterior resection without stoma or laparoscopic right hemicolectomy.
  • American Society of Anaesthetists physical status (ASA) 1-3

You may not qualify if:

  • Opioid tolerance
  • Chronic abdominal pain
  • Allergy/Intolerance: Morphine, local anaesthetics
  • BMI\>35 Kg/M2
  • Previous major abdominal surgery
  • High likelihood of conversion to open procedure
  • Patients unable to communicate in written and spoken English
  • Weight less than 50 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Churchill Hospital, Oxford Radcliffe Hospitals NHS trust

Oxford, Oxfordshire, OX3 9DU, United Kingdom

Location

Related Publications (4)

  • Zafar N, Davies R, Greenslade GL, Dixon AR. The evolution of analgesia in an 'accelerated' recovery programme for resectional laparoscopic colorectal surgery with anastomosis. Colorectal Dis. 2010 Feb;12(2):119-24. doi: 10.1111/j.1463-1318.2009.01768.x. Epub 2009 Jan 16.

    PMID: 19207712BACKGROUND
  • McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f.

    PMID: 17179269BACKGROUND
  • McDonnell JG, O'Donnell BD, Farrell T, Gough N, Tuite D, Power C, Laffey JG. Transversus abdominis plane block: a cadaveric and radiological evaluation. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):399-404. doi: 10.1016/j.rapm.2007.03.011.

    PMID: 17961838BACKGROUND
  • El-Dawlatly AA, Turkistani A, Kettner SC, Machata AM, Delvi MB, Thallaj A, Kapral S, Marhofer P. Ultrasound-guided transversus abdominis plane block: description of a new technique and comparison with conventional systemic analgesia during laparoscopic cholecystectomy. Br J Anaesth. 2009 Jun;102(6):763-7. doi: 10.1093/bja/aep067. Epub 2009 Apr 17.

    PMID: 19376789BACKGROUND

MeSH Terms

Conditions

Colonic NeoplasmsRectal NeoplasmsDiverticulum, ColonColitis, Ulcerative

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesDiverticulumDiverticular DiseasesGastroenteritisPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsColitisInflammatory Bowel Diseases

Limitations and Caveats

Smaller number of subjects analysed than planned. Presented data should be carefully interpreted (and no conclusions should be drawn) since not enough patients were analyzed.

Results Point of Contact

Title
Dr Nicholas Crabtree
Organization
Oxford University Hospitals NHS Trust

Study Officials

  • Nicholas Crabtree, MB,ChB, FRCA

    Nuffield Department of Anaesthetics, Oxford Radcliffe Hospitals NHS Trust , Oxford

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Anaesthetist

Study Record Dates

First Submitted

April 18, 2011

First Posted

April 20, 2011

Study Start

September 1, 2011

Primary Completion

December 1, 2013

Study Completion

December 1, 2015

Last Updated

February 5, 2020

Results First Posted

February 5, 2020

Record last verified: 2020-01

Locations